ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure

Chronic Heart Failure Clinical Trial

— ALERT-HF  

Official title:

ALERT-HF:Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01813331
• Other study ID #: 161/12
• Status: Completed
• Phase: N/A
• First received: March 7, 2013
• Last updated: March 13, 2013
• Start date: November 2012
• Est. completion date: February 2013

Study information

• Verified date: March 2013
• Source: Federico II University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Federico II University
• Study type: Observational [Patient Registry]

Clinical Trial Summary

ALERT-HF is an observational study aimed to evaluate the diagnostic criteria adopted and the adherence to the current therapeutic guidelines in a large series of patients affected with chronic heart failure. Secondary objective is to evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 660
• Est. completion date: February 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of Heart Failure

• Signature of informed consent

• Age older than 65 years

Exclusion Criteria:

• indication for cardiac surgery or cardiac surgery by less than 3 months

• age less than 65 years

• inability to perform periodic checks

• presence of malignant neoplasms and other severe diseases.

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Chronic Heart Failure
• Heart Failure

Locations

Country	Name	City	State
Italy	ARCA Campania healthcare ambulatories	Naples

Sponsors (1)

Lead Sponsor	Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients treated with each of the following indicators of adherence to the current therapeutic guidelines:-ACEI -ARB -beta blockers -loop diuretics -aldosterone antagonists -digoxin -anticoagulant therapy - implantation of cardiac devices		first physical examination and clinical evaluation performed during a 3 months period, from November 2012 to January 2013	Yes
Secondary	evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district		first evaluation	Yes